how glp 1 medications are changing consumer behavior Harvard Business Review | A PwC analysis shows that GLP-1 like Ozempic and Zepbound may be catalyzing a behavioral and economic shift on par with major How GLP-1s Are Reshaping Consumer

GLP-1 medications can help reduce appetite, so listen to your bodys hunger cues and avoid overeating

There is a theoretical increased risk of medullary thyroid cancers, but its not clear how likely this is to actually happen in people, says Fishman, who along with Vash stresses that the link has only ever been studied in animals

(For Zepbound, the weight-loss version of Mounjaro, available doses are 2.5 mg, 5 mg, 10 mg, and 15 mg taken by injection once weekly, with 15 mg being the maximum dose.) Learn more about administering these medicines in: Ozempic Injection: Where and How to Inject and Mounjaro Injection: Where and How to Inject

On the day, allow about fifteen minutes